The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer

• Главные авторы: T. A. Bogush (Автор), E. A. Dudko (Автор), E. A. Bogush (Автор), B. E. Polotsky (Автор), S. A. Tyulyandin (Автор), M. I. Davydov (Автор)
• Формат: ‌
• Опубликовано: ABV-press, 2014-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The antiestrogen tamoxifen was examined for its effect on the interaction of monoclonal antibodies with the multidrug resistance markers: with Pgp and MRP1 in the cultured T-lymphoblast leukemia cell line Jurkat and with BCRP in the cultured cervical cancer cell line HeLa. The investigation used imm...